Compare IMO & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMO | KVUE |
|---|---|---|
| Founded | 1880 | 2022 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Specialty Chemicals |
| Sector | Energy | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4B | 39.9B |
| IPO Year | N/A | 2023 |
| Metric | IMO | KVUE |
|---|---|---|
| Price | $92.13 | $17.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $115.00 | $20.31 |
| AVG Volume (30 Days) | 506.7K | ★ 37.7M |
| Earning Date | 01-30-2026 | 11-03-2025 |
| Dividend Yield | 2.24% | ★ 4.79% |
| EPS Growth | N/A | ★ 35.31 |
| EPS | ★ 5.63 | 0.75 |
| Revenue | ★ $34,726,360,295.00 | $15,006,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.37 | $2.81 |
| P/E Ratio | ★ $15.88 | $23.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $58.76 | $14.02 |
| 52 Week High | $101.01 | $25.17 |
| Indicator | IMO | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 60.90 |
| Support Level | $90.02 | $16.70 |
| Resistance Level | $96.73 | $17.59 |
| Average True Range (ATR) | 2.22 | 0.31 |
| MACD | -0.85 | 0.03 |
| Stochastic Oscillator | 18.62 | 76.29 |
Imperial Oil Ltd is an integrated oil company active in all phases of the petroleum industry in Canada, including the exploration for, and production and sale of, crude oil, natural gas, petroleum products, and petrochemicals. It also pursues lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. The company's reportable segments are Upstream, Downstream, and Chemical. Maximum revenue for the company is generated from its Downstream segment, which refines crude oil into petroleum products and distributes and market these products. The Upstream segment explores and produces crude oil, its equivalents, and natural gas, and the Chemical segment manufactures and markets hydrocarbon-based chemicals and chemical products.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.